Clinical Trial Update: Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

View source ↗

Summary

Ongoing multicenter clinical trial evaluating a 3-gene methylation-based detection kit for hepatocellular carcinoma using a PCR fluorescent probe method.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Singlera Genomics Inc. | Conditions: Hepatocellular Carcinoma (HCC) | Status: ACTIVE_NOT_RECRUITING